Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads a column summarizing the findings from two leading healthcare centers, John Hopkins University and Mayo Clinic, on the effectiveness of the mRNA vaccinations for transplant recipients. After one dose of the Pfizer or Moderna vaccines, researchers found the effectiveness to be significantly less in transplant recipients who are immunosuppressed compared to those who aren’t. However, more hope was provided after they studied the second dose as transplant patients were increasingly protected, albeit still less than those of their healthy counterparts.

Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com

Podden och tillhörande omslagsbild på den här sidan tillhör Pulmonary Fibrosis News. Innehållet i podden är skapat av Pulmonary Fibrosis News och inte av, eller tillsammans med, Poddtoppen.